In addition to HR, other established BC susceptibility genes such as BRCA1, BRCA2, PTEN, ESR1, and TP53, were also included in the targeted sequencing panel in order to compare the HR mutation rate relative to that of these genes in the same patient cohort (Supplementary Table S1). The gene discussed is TP53; the disease is breast cancer.